Qiagen

Euronext Amsterdam · LEI 54930036WK3GMCN17Z57· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Reference: average annual pay in Healthcare & Pharma, Netherlands: $54.6K (Eurostat earn_ses22_26 (SES 2022), 2022 · full-time equivalent, firms with 10+ staff). Official government wage statistics for the whole industry, not this company's pay. Definitions differ by country; see the source.

Quick read

  • Revenue grew 5.7% year over year.
  • Operating margin was 22.4% in 2025.

Last 3 years

Revenue
$2.0B2024$2.1B2025
Operating income
$117.3M2024$467.6M2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
22.4%
Net margin
20.9%
ROE
11.1%
Debt-to-equity
61.9%
Equity ratio
61.8%

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

Source: ESEF annual report via filings.xbrl.org · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.